1 Introduction to Research & Analysis Reports
1.1 Ceftazidime Avibactam Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Ceftazidime Avibactam Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Ceftazidime Avibactam Overall Market Size
2.1 Global Ceftazidime Avibactam Market Size: 2022 VS 2029
2.2 Global Ceftazidime Avibactam Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Ceftazidime Avibactam Sales: 2018-2029
3 Company Landscape
3.1 Top Ceftazidime Avibactam Players in Global Market
3.2 Top Global Ceftazidime Avibactam Companies Ranked by Revenue
3.3 Global Ceftazidime Avibactam Revenue by Companies
3.4 Global Ceftazidime Avibactam Sales by Companies
3.5 Global Ceftazidime Avibactam Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Ceftazidime Avibactam Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Ceftazidime Avibactam Product Type
3.8 Tier 1, Tier 2 and Tier 3 Ceftazidime Avibactam Players in Global Market
3.8.1 List of Global Tier 1 Ceftazidime Avibactam Companies
3.8.2 List of Global Tier 2 and Tier 3 Ceftazidime Avibactam Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Ceftazidime Avibactam Market Size Markets, 2022 & 2029
4.1.2 2.5 g Type
4.1.3 Others
4.2 By Type – Global Ceftazidime Avibactam Revenue & Forecasts
4.2.1 By Type – Global Ceftazidime Avibactam Revenue, 2018-2023
4.2.2 By Type – Global Ceftazidime Avibactam Revenue, 2024-2029
4.2.3 By Type – Global Ceftazidime Avibactam Revenue Market Share, 2018-2029
4.3 By Type – Global Ceftazidime Avibactam Sales & Forecasts
4.3.1 By Type – Global Ceftazidime Avibactam Sales, 2018-2023
4.3.2 By Type – Global Ceftazidime Avibactam Sales, 2024-2029
4.3.3 By Type – Global Ceftazidime Avibactam Sales Market Share, 2018-2029
4.4 By Type – Global Ceftazidime Avibactam Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Ceftazidime Avibactam Market Size, 2022 & 2029
5.1.2 Complicated Intra-abdominal Infection
5.1.3 Hospital Acquired Pneumonia
5.1.4 Ventilator-associated Pneumonia
5.2 By Application – Global Ceftazidime Avibactam Revenue & Forecasts
5.2.1 By Application – Global Ceftazidime Avibactam Revenue, 2018-2023
5.2.2 By Application – Global Ceftazidime Avibactam Revenue, 2024-2029
5.2.3 By Application – Global Ceftazidime Avibactam Revenue Market Share, 2018-2029
5.3 By Application – Global Ceftazidime Avibactam Sales & Forecasts
5.3.1 By Application – Global Ceftazidime Avibactam Sales, 2018-2023
5.3.2 By Application – Global Ceftazidime Avibactam Sales, 2024-2029
5.3.3 By Application – Global Ceftazidime Avibactam Sales Market Share, 2018-2029
5.4 By Application – Global Ceftazidime Avibactam Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Ceftazidime Avibactam Market Size, 2022 & 2029
6.2 By Region – Global Ceftazidime Avibactam Revenue & Forecasts
6.2.1 By Region – Global Ceftazidime Avibactam Revenue, 2018-2023
6.2.2 By Region – Global Ceftazidime Avibactam Revenue, 2024-2029
6.2.3 By Region – Global Ceftazidime Avibactam Revenue Market Share, 2018-2029
6.3 By Region – Global Ceftazidime Avibactam Sales & Forecasts
6.3.1 By Region – Global Ceftazidime Avibactam Sales, 2018-2023
6.3.2 By Region – Global Ceftazidime Avibactam Sales, 2024-2029
6.3.3 By Region – Global Ceftazidime Avibactam Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Ceftazidime Avibactam Revenue, 2018-2029
6.4.2 By Country – North America Ceftazidime Avibactam Sales, 2018-2029
6.4.3 US Ceftazidime Avibactam Market Size, 2018-2029
6.4.4 Canada Ceftazidime Avibactam Market Size, 2018-2029
6.4.5 Mexico Ceftazidime Avibactam Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Ceftazidime Avibactam Revenue, 2018-2029
6.5.2 By Country – Europe Ceftazidime Avibactam Sales, 2018-2029
6.5.3 Germany Ceftazidime Avibactam Market Size, 2018-2029
6.5.4 France Ceftazidime Avibactam Market Size, 2018-2029
6.5.5 U.K. Ceftazidime Avibactam Market Size, 2018-2029
6.5.6 Italy Ceftazidime Avibactam Market Size, 2018-2029
6.5.7 Russia Ceftazidime Avibactam Market Size, 2018-2029
6.5.8 Nordic Countries Ceftazidime Avibactam Market Size, 2018-2029
6.5.9 Benelux Ceftazidime Avibactam Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Ceftazidime Avibactam Revenue, 2018-2029
6.6.2 By Region – Asia Ceftazidime Avibactam Sales, 2018-2029
6.6.3 China Ceftazidime Avibactam Market Size, 2018-2029
6.6.4 Japan Ceftazidime Avibactam Market Size, 2018-2029
6.6.5 South Korea Ceftazidime Avibactam Market Size, 2018-2029
6.6.6 Southeast Asia Ceftazidime Avibactam Market Size, 2018-2029
6.6.7 India Ceftazidime Avibactam Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Ceftazidime Avibactam Revenue, 2018-2029
6.7.2 By Country – South America Ceftazidime Avibactam Sales, 2018-2029
6.7.3 Brazil Ceftazidime Avibactam Market Size, 2018-2029
6.7.4 Argentina Ceftazidime Avibactam Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Ceftazidime Avibactam Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Ceftazidime Avibactam Sales, 2018-2029
6.8.3 Turkey Ceftazidime Avibactam Market Size, 2018-2029
6.8.4 Israel Ceftazidime Avibactam Market Size, 2018-2029
6.8.5 Saudi Arabia Ceftazidime Avibactam Market Size, 2018-2029
6.8.6 UAE Ceftazidime Avibactam Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Allergan
7.1.1 Allergan Company Summary
7.1.2 Allergan Business Overview
7.1.3 Allergan Ceftazidime Avibactam Major Product Offerings
7.1.4 Allergan Ceftazidime Avibactam Sales and Revenue in Global (2018-2023)
7.1.5 Allergan Key News & Latest Developments
7.2 Pfizer
7.2.1 Pfizer Company Summary
7.2.2 Pfizer Business Overview
7.2.3 Pfizer Ceftazidime Avibactam Major Product Offerings
7.2.4 Pfizer Ceftazidime Avibactam Sales and Revenue in Global (2018-2023)
7.2.5 Pfizer Key News & Latest Developments
7.3 QILU Pharmaceutical
7.3.1 QILU Pharmaceutical Company Summary
7.3.2 QILU Pharmaceutical Business Overview
7.3.3 QILU Pharmaceutical Ceftazidime Avibactam Major Product Offerings
7.3.4 QILU Pharmaceutical Ceftazidime Avibactam Sales and Revenue in Global (2018-2023)
7.3.5 QILU Pharmaceutical Key News & Latest Developments
8 Global Ceftazidime Avibactam Production Capacity, Analysis
8.1 Global Ceftazidime Avibactam Production Capacity, 2018-2029
8.2 Ceftazidime Avibactam Production Capacity of Key Manufacturers in Global Market
8.3 Global Ceftazidime Avibactam Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Ceftazidime Avibactam Supply Chain Analysis
10.1 Ceftazidime Avibactam Industry Value Chain
10.2 Ceftazidime Avibactam Upstream Market
10.3 Ceftazidime Avibactam Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Ceftazidime Avibactam Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
Table 1. Key Players of Ceftazidime Avibactam in Global Market
Table 2. Top Ceftazidime Avibactam Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Ceftazidime Avibactam Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Ceftazidime Avibactam Revenue Share by Companies, 2018-2023
Table 5. Global Ceftazidime Avibactam Sales by Companies, (K Units), 2018-2023
Table 6. Global Ceftazidime Avibactam Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Ceftazidime Avibactam Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers Ceftazidime Avibactam Product Type
Table 9. List of Global Tier 1 Ceftazidime Avibactam Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Ceftazidime Avibactam Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Ceftazidime Avibactam Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Ceftazidime Avibactam Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Ceftazidime Avibactam Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Ceftazidime Avibactam Sales (K Units), 2018-2023
Table 15. By Type - Global Ceftazidime Avibactam Sales (K Units), 2024-2029
Table 16. By Application – Global Ceftazidime Avibactam Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Ceftazidime Avibactam Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Ceftazidime Avibactam Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Ceftazidime Avibactam Sales (K Units), 2018-2023
Table 20. By Application - Global Ceftazidime Avibactam Sales (K Units), 2024-2029
Table 21. By Region – Global Ceftazidime Avibactam Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Ceftazidime Avibactam Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Ceftazidime Avibactam Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Ceftazidime Avibactam Sales (K Units), 2018-2023
Table 25. By Region - Global Ceftazidime Avibactam Sales (K Units), 2024-2029
Table 26. By Country - North America Ceftazidime Avibactam Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Ceftazidime Avibactam Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Ceftazidime Avibactam Sales, (K Units), 2018-2023
Table 29. By Country - North America Ceftazidime Avibactam Sales, (K Units), 2024-2029
Table 30. By Country - Europe Ceftazidime Avibactam Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Ceftazidime Avibactam Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Ceftazidime Avibactam Sales, (K Units), 2018-2023
Table 33. By Country - Europe Ceftazidime Avibactam Sales, (K Units), 2024-2029
Table 34. By Region - Asia Ceftazidime Avibactam Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Ceftazidime Avibactam Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Ceftazidime Avibactam Sales, (K Units), 2018-2023
Table 37. By Region - Asia Ceftazidime Avibactam Sales, (K Units), 2024-2029
Table 38. By Country - South America Ceftazidime Avibactam Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Ceftazidime Avibactam Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Ceftazidime Avibactam Sales, (K Units), 2018-2023
Table 41. By Country - South America Ceftazidime Avibactam Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Ceftazidime Avibactam Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Ceftazidime Avibactam Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Ceftazidime Avibactam Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Ceftazidime Avibactam Sales, (K Units), 2024-2029
Table 46. Allergan Company Summary
Table 47. Allergan Ceftazidime Avibactam Product Offerings
Table 48. Allergan Ceftazidime Avibactam Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. Allergan Key News & Latest Developments
Table 50. Pfizer Company Summary
Table 51. Pfizer Ceftazidime Avibactam Product Offerings
Table 52. Pfizer Ceftazidime Avibactam Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 53. Pfizer Key News & Latest Developments
Table 54. QILU Pharmaceutical Company Summary
Table 55. QILU Pharmaceutical Ceftazidime Avibactam Product Offerings
Table 56. QILU Pharmaceutical Ceftazidime Avibactam Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 57. QILU Pharmaceutical Key News & Latest Developments
Table 58. Ceftazidime Avibactam Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 59. Global Ceftazidime Avibactam Capacity Market Share of Key Manufacturers, 2021-2023
Table 60. Global Ceftazidime Avibactam Production by Region, 2018-2023 (K Units)
Table 61. Global Ceftazidime Avibactam Production by Region, 2024-2029 (K Units)
Table 62. Ceftazidime Avibactam Market Opportunities & Trends in Global Market
Table 63. Ceftazidime Avibactam Market Drivers in Global Market
Table 64. Ceftazidime Avibactam Market Restraints in Global Market
Table 65. Ceftazidime Avibactam Raw Materials
Table 66. Ceftazidime Avibactam Raw Materials Suppliers in Global Market
Table 67. Typical Ceftazidime Avibactam Downstream
Table 68. Ceftazidime Avibactam Downstream Clients in Global Market
Table 69. Ceftazidime Avibactam Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Ceftazidime Avibactam Segment by Type in 2022
Figure 2. Ceftazidime Avibactam Segment by Application in 2022
Figure 3. Global Ceftazidime Avibactam Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Ceftazidime Avibactam Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Ceftazidime Avibactam Revenue, 2018-2029 (US$, Mn)
Figure 7. Ceftazidime Avibactam Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Ceftazidime Avibactam Revenue in 2022
Figure 9. By Type - Global Ceftazidime Avibactam Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Ceftazidime Avibactam Revenue Market Share, 2018-2029
Figure 11. By Type - Global Ceftazidime Avibactam Sales Market Share, 2018-2029
Figure 12. By Type - Global Ceftazidime Avibactam Price (US$/Unit), 2018-2029
Figure 13. By Application - Global Ceftazidime Avibactam Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Ceftazidime Avibactam Revenue Market Share, 2018-2029
Figure 15. By Application - Global Ceftazidime Avibactam Sales Market Share, 2018-2029
Figure 16. By Application - Global Ceftazidime Avibactam Price (US$/Unit), 2018-2029
Figure 17. By Region - Global Ceftazidime Avibactam Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Ceftazidime Avibactam Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Ceftazidime Avibactam Revenue Market Share, 2018-2029
Figure 20. By Region - Global Ceftazidime Avibactam Sales Market Share, 2018-2029
Figure 21. By Country - North America Ceftazidime Avibactam Revenue Market Share, 2018-2029
Figure 22. By Country - North America Ceftazidime Avibactam Sales Market Share, 2018-2029
Figure 23. US Ceftazidime Avibactam Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Ceftazidime Avibactam Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Ceftazidime Avibactam Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Ceftazidime Avibactam Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Ceftazidime Avibactam Sales Market Share, 2018-2029
Figure 28. Germany Ceftazidime Avibactam Revenue, (US$, Mn), 2018-2029
Figure 29. France Ceftazidime Avibactam Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Ceftazidime Avibactam Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Ceftazidime Avibactam Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Ceftazidime Avibactam Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Ceftazidime Avibactam Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Ceftazidime Avibactam Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Ceftazidime Avibactam Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Ceftazidime Avibactam Sales Market Share, 2018-2029
Figure 37. China Ceftazidime Avibactam Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Ceftazidime Avibactam Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Ceftazidime Avibactam Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Ceftazidime Avibactam Revenue, (US$, Mn), 2018-2029
Figure 41. India Ceftazidime Avibactam Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Ceftazidime Avibactam Revenue Market Share, 2018-2029
Figure 43. By Country - South America Ceftazidime Avibactam Sales Market Share, 2018-2029
Figure 44. Brazil Ceftazidime Avibactam Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Ceftazidime Avibactam Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Ceftazidime Avibactam Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Ceftazidime Avibactam Sales Market Share, 2018-2029
Figure 48. Turkey Ceftazidime Avibactam Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Ceftazidime Avibactam Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Ceftazidime Avibactam Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Ceftazidime Avibactam Revenue, (US$, Mn), 2018-2029
Figure 52. Global Ceftazidime Avibactam Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Ceftazidime Avibactam by Region, 2022 VS 2029
Figure 54. Ceftazidime Avibactam Industry Value Chain
Figure 55. Marketing Channels
※参考情報 セフタジジムアビバクタムは、抗生物質の一種であり、複雑な環境においても効果を発揮する新しい世代の医薬品です。この薬剤は、特に多剤耐性菌に対抗するために開発されており、グラム陰性菌に対する有効性が期待されています。以下では、セフタジジムアビバクタムの概念について詳細に述べます。 セフタジジムアビバクタムは、セフタジジムとアビバクタムという2つの成分からなる配合薬です。セフタジジムはセフェム系抗生物質であり、β-ラクタム系抗生物質に分類されます。この薬剤は、細菌の細胞壁合成を阻害することで抗菌作用を示します。一方、アビバクタムはβ-ラクタマーゼ阻害剤であり、これによりセフタジジムの効果を保護し、耐性を持つ細菌に対しても有効に作用します。この二つの成分が組み合わさることで、感染症に対する広範な戦略が提供されます。 セフタジジム自体は、特に緑膿菌や腸内桿菌科の一部といった多くのグラム陰性菌に対して効果があります。しかし、これらの細菌はβ-ラクタマーゼを産生することで抗生物質に対する耐性を獲得することが多く、これが治療の妨げとなることがあります。アビバクタムの添加によって、これらの耐性のメカニズムを克服し、臨床において効果的な治療を可能にします。 この薬剤の使用は、特に重篤な感染症や入院患者において重要です。多剤耐性菌によって引き起こされる肺炎、尿路感染症、腹膜炎、菌血症などの病態に対して、セフタジジムアビバクタムは治療選択肢として用いられています。さらには、他の抗生物質に対する耐性を示す細菌に感染した場合でも、セフタジジムアビバクタムが有効であることが多いため、特に感染症の重症化を防ぐ手段として評価されています。 医療現場においては、抗生物質の適正使用が求められています。多剤耐性菌の増加は大きな問題であり、これに対抗するためには新たな治療法の開発が必要です。セフタジジムアビバクタムは、こうしたニーズに応える形で登場しました。まだ比較的新しい薬剤であるため、その使用に際しては慎重な観察が必要ですが、実際に使用される場面が増えており、患者の治療において有望な候補となっています。 また、セフタジジムアビバクタムは、他の抗生物質との併用療法においても効果を発揮することがあります。特に、β-ラクタム系薬剤との併用により、相乗的な抗菌効果が期待できます。このように、セフタジジムアビバクタムは、単独で使用するだけでなく、他の抗生物質と組み合わせることにより、より効果的な治療戦略を構築することが可能です。 それに加え、セフタジジムアビバクタムの開発は、抗生物質に対する耐性のメカニズムを理解する上でも重要です。耐性の進化を予測し、それに対抗するための新たな抗菌薬の開発につながる可能性があります。そのため、研究者や医療従事者は、セフタジジムアビバクタムの使用データを積極的に収集し、分析を行うことで、さらなる知見を得ることが期待されています。 このように、セフタジジムアビバクタムは今日の医療現場において非常に重要な役割を果たしており、多剤耐性菌による感染症に対処するための新しい武器とされています。今後の研究や臨床の進展により、その使用の幅が広がることが期待されています。抗生物質の効果が持続可能であるために、新しい治療法の開発と併用療法の研究が今後ますます重要性を増していくことでしょう。このような観点からも、セフタジジムアビバクタムは現代医療における有用な資源であることは間違いありません。 |
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer